What is kisspeptin-10?
The KISS1 gene was discovered in 1996 by researchers in Hershey, Pennsylvania, who were studying genes that suppress the spread of melanoma, and it was named after the chocolate kisses the town is known for. The gene makes a larger protein that is cut into several active kisspeptins of different lengths, including kisspeptin-54, kisspeptin-14, kisspeptin-13 and kisspeptin-10. All share the same final 10 amino acids, which is the part that activates the receptor.
Its role in reproduction became clear in 2003, when two research groups found that people with faulty kisspeptin receptors do not go through puberty normally. That is why it is sometimes called the puberty peptide. Since then, kisspeptin has been recognized as a key upstream switch for the whole reproductive hormone system in both men and women.
How does kisspeptin-10 work?
Kisspeptin acts on receptors called KISS1R, also known as GPR54, found on GnRH neurons in the hypothalamus. Activating them triggers release of gonadotropin-releasing hormone (GnRH), which tells the pituitary to release LH and FSH. In men, LH and FSH signal the testes to make testosterone and sperm. In women, they drive follicle growth, estrogen production and ovulation. Because kisspeptin-10 works at the top of this chain, its effects depend on the pituitary and gonads being able to respond.
What has kisspeptin-10 research looked at?
- Hormone levels in men
- In small studies in healthy men, kisspeptin-10 raised LH and testosterone levels in the short term.
- Hormone levels in women
- In women, the response varied with the menstrual cycle, with much stronger LH responses just before ovulation than early in the cycle.
- IVF egg maturation
- Most fertility trials used the longer form, kisspeptin-54, which has been tested as a trigger for final egg maturation in IVF in women at high risk of ovarian hyperstimulation.
- Sexual and emotional brain processing
- Small brain-imaging studies, which used kisspeptin-54, reported that kisspeptin changed brain activity in response to sexual and romantic images, including in men and women with low sexual desire.
- Puberty and hormone disorders
- Researchers have explored kisspeptin as a test to help tell apart causes of delayed puberty and low reproductive hormones.
The human research consistently shows that kisspeptin can switch on the reproductive hormone system in the short term. What is missing is long-term data, especially on repeated use of kisspeptin-10, and evidence on outcomes beyond hormone levels, such as fertility or how people feel.
Kisspeptin-10 vs kisspeptin-54
Both forms activate the same receptor. Kisspeptin-10 is the minimal active piece and is broken down within minutes, so its hormone effects are brief. Kisspeptin-54 is the full-length form and lasts longer, which is why most fertility and brain-imaging studies have used it. Findings from kisspeptin-54 studies are often quoted online as if they applied to kisspeptin-10, but the two do not behave identically in the body.
Kisspeptin-10 side effects and cautions
In the short human studies so far, kisspeptin-10 was generally well tolerated, with few side effects reported. These studies were small and brief, so less common or long-term effects would not have been detected. With continuous or frequent exposure, the hormone system can become desensitized, so the response may fade, a pattern also seen with GnRH drugs. Anyone with health questions about it should talk to a qualified clinician.
- Downstream hormone effects
- Because it raises LH, FSH and sex hormones, it may share the cautions of those hormones, including for hormone-sensitive cancers.
- Desensitization
- Frequent or continuous exposure to kisspeptin blunted the hormone response in animal studies and in a human study of kisspeptin-54.
- Pregnancy
- Its safety in pregnancy and breastfeeding has not been established.
- Long-term use
- There is no long-term safety data in humans.
Further reading
This page summarizes the research in plain words. To read the studies yourself:
- Published studies on Kisspeptin-10 PubMed, US National Library of Medicine
- Registered human trials of Kisspeptin-10 ClinicalTrials.gov



